SI‑BONE Insider Buying Signals Potential Upswing Amid Positive Clinical and Governance Developments
SI‑BONE insider buy: Jeryl H. Hilleman snaps up 10,957 shares amid a 33% rally, signaling confidence in the company’s clinical pipeline and governance strength.
3 minutes to read



